MPEMX Performance — Mondrian Emerging Markets Value Equity Fund, Institutional Class
Data updated: 2026-09-28
MPEMX returned +2.18% year to date and +29.56% over one year to Jul 2026. Annualised returns are +17.19% over 3 years and +7.94% over 5 years. The fund trailed its Emerging Markets Equity category average: $100 invested three years ago grew to $161, against $164 for the category, and to $130 over one year, against $134. Volatility over the past three years was 13.78% a year. In the 12 months to Jul 2026 the fund lost a net $2.5M, and assets reached $23.79M.
MPEMX Growth of $100
What $100 invested in Mondrian Emerging Markets Value Equity Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Emerging Markets Equity category average over the same months.
| Period | MPEMX | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $130 | $134 |
| 3 years (Aug 2023 – Jul 2026) | $161 | $164 |
| 5 years (Aug 2021 – Jul 2026) | $147 | $143 |
| Since data start (Feb 2020 – Jul 2026) | $179 | $183 |
MPEMX Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +2.18% |
| 1 year | +29.56% |
| 3 years (annualised) | +17.19% |
| 5 years (annualised) | +7.94% |
MPEMX Annual Returns
Calendar-year total returns of Mondrian Emerging Markets Value Equity Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | +2.18% |
| 2025 | +44.90% |
| 2024 | +22.57% |
| 2023 | +6.81% |
| 2022 | −26.13% |
| 2021 | +5.39% |
| 2020 (Feb–Dec) | +18.35% |
MPEMX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | −0.7% | +6.1% | −8.6% | +4.3% | +1.2% | −1.9% | +2.5% | — | — | — | — | — |
| 2025 | −2.8% | +2.6% | +2.0% | +1.3% | +1.4% | +4.6% | +4.6% | +4.5% | +5.8% | +2.8% | +9.1% | +2.3% |
| 2024 | +6.5% | −1.2% | +2.9% | +5.3% | 0.0% | +2.1% | +1.7% | −5.6% | +6.4% | +2.3% | +1.9% | −1.3% |
| 2023 | +18.0% | −1.3% | +2.9% | −7.3% | +4.7% | +5.2% | −1.7% | −2.9% | −2.0% | −6.3% | −5.1% | +4.7% |
| 2022 | −5.0% | −7.5% | −3.7% | −4.5% | −0.6% | −5.7% | +4.5% | −2.3% | −10.5% | −2.3% | +11.4% | −2.2% |
| 2021 | +7.9% | +1.7% | −1.7% | +1.3% | −6.9% | −0.7% | +2.1% | +1.7% | −4.5% | +0.3% | +2.0% | +3.0% |
| 2020 | — | +9.8% | −18.3% | −4.4% | +11.4% | +6.2% | −0.5% | +2.0% | −0.9% | +1.8% | +4.4% | +9.1% |
MPEMX Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 13.78%
- 3-year Sharpe ratio: 0.92 (vs 4.5% risk-free rate)
- Best month: +9.05% (Nov 2025)
- Worst month: −8.59% (Mar 2026)
MPEMX Fund Flows
Monthly money in and out of Mondrian Emerging Markets Value Equity Fund, from SEC Form N-PORT.
- 12-month net flow: −$2.5M
- 12-month gross sales (incl. reinvestments): $3.3M
- Sales ÷ redemptions: 0.57×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $99K | $56K | $43K |
| Jun 2026 | $84K | $61K | $24K |
| May 2026 | $1.3M | $56K | $1.3M |
| Apr 2026 | $837K | $1.1M | −$258K |
| Mar 2026 | $101K | $531K | −$429K |
| Feb 2026 | $17K | $68K | −$51K |
| Jan 2026 | $32K | $802K | −$771K |
| Dec 2025 | $804K | $2.0M | −$1.2M |
| Nov 2025 | $11K | $54K | −$43K |
| Oct 2025 | $7K | $236K | −$229K |
| Sep 2025 | $9K | $83K | −$74K |
| Aug 2025 | $737 | $836K | −$836K |
MPEMX Assets Under Management
Net assets of Mondrian Emerging Markets Value Equity Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $23.79M |
| 2026-04-30 | $22.02M |
| 2026-01-31 | $22.54M |
| 2025-10-31 | $23.14M |
| 2025-07-31 | $21.39M |
| 2025-04-30 | $19.72M |
| 2025-01-31 | $20.13M |
| 2024-10-31 | $20.62M |
| 2024-07-31 | $20.61M |
| 2024-04-30 | $19.55M |
| 2024-01-31 | $19.47M |
| 2023-10-31 | $19.04M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.